Dear all It is a pleasure to share the attached after a long time. We have established a “Dedicated Vaccination Centre” on the eve of introducing bivalent OPV and IPV in April 2016. The story was shared in 2016. Now, after 7 years, realizing the dream of establishing the same in East Point College ...

Dear viewers, we wish to share the attached with the techNet community          This year on 14th November 2019, we celebrated “EuVac award ceremony” in our college to felicitate the parents for getting their children graduated timely with primary vaccination before first b...

Dear all I encountered operational challege were during SIA, specifically OBR using mOPV2 antigen. I observed that the fixed post team were given only bOPV which is the right antigen for routine while ignoring the purpose of the campaign (mOPV2 not given). They were intructed to give both mOPV2 and...

Hello everyone! This is my very first post here. I am a 3rd year Student of Medicine(M.B.B.S) studying at KVG Medical College & Hospital, Sullia, India. Attched is a PDF file which is the original document...Please go through that as it has pictures. Whatever text that follows this is a copy from ...

From 17 April to 1 May, the globally synchronised switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV) is taking place in 155 countries and territories. This will be followed by an intensive monitoring and validation phase through to 18 May. To follow progress as co...

Dear viewers Context: India in collaboration with development partners like WHO/UNICEF/USAID/MCHIP etc has made remarkable advances in the last ten years: introduction of Measles 2nd dose, HepB vaccine including Birth dose vaccine, JE 2 doses, Pentavalent vaccine, year 2012-13 declared as year of ...

The Strategic Advisory Group of Experts on immunization (SAGE) convened by WHO on 20 October 2015 has confirmed that the globally coordinated withdrawal of the type 2 component in the oral poliovirus vaccine (OPV) will take place in April 2016. SAGE’s landmark decision follows the endorsement by th...

WHO recommends 2 temperature ranges for keeping all vaccines at health facilities (+2C +8C) and (-15C -25C) for OPV above district level. The rationale for using first range is explained in “Thermostability of vaccines”. What is the reason for use of second range (-15C -25C) for OPV and some freez...